Keppel Pacific Oak US REIT (KORE)

Broker's Calls

RHB remains 'overweight' on US office REITs despite drop in unit prices

Analyst Vijay Natarajan remains positive on the sector as recessionary fears in the US could force workers back to the office.
KORE divests Northridge Center I & II in Atlanta for US$22.1 mil - THE EDGE SINGAPORE

REITs

KORE divests Northridge Center I & II in Atlanta for US$22.1 mil

The consideration was satisfied in cash and is 16.9% above its last independent valuation as at Dec 31, 2021.
KORE reports 1HFY2022 DPU of 3.02 US cents, down 4.4% - THE EDGE SINGAPORE

Results

KORE reports 1HFY2022 DPU of 3.02 US cents, down 4.4%

On a like-for-like basis, KORE’s adjusted DPU increased by 0.7% y-o-y for the 2QFY2022 and 1HFY2022.

kopi-C: the Company brew

KORE: Driving sustainability and unlocking value

The REIT will continue to seek high-quality and value-accretive acquisitions across the US,

Broker's Calls

UOB Kay Hian keeps ‘buy’ on KORE in light of fast rising organic growth from core cities

KORE has presence in Atlanta, Dallas, Denver and Orlando, which accounts for 34.4% of its AUM

Broker's Calls

RHB keeps ‘buy’ rating on Keppel Pacific Oak US REIT on stable returns

KORE delivered a solid 1QFY2022 ended March with distributable income up 11% y-o-y and an estimated DPU of 1.6 cents (+1% y-o-y)
KORE reports 10.9% growth y-o-y in distributable income in 1Q2022 - THE EDGE SINGAPORE

Results

KORE reports 10.9% growth y-o-y in distributable income in 1Q2022

KORE reports 10.9% y-o-y rise in 1Q2022 distributable income

REITs

REITs can offset impact of rising rates with a more defensive portfolio

KORE opts for defensive campus style properties as shelter from rising rates and inflation

Broker's Calls

Broker's Digest: FCT, MLT, KORE

Here's what the analysts have to say.
Analysts like Keppel Pacific Oak US REIT for steady performance - THE EDGE SINGAPORE

Broker's Calls

Analysts like Keppel Pacific Oak US REIT for steady performance

RHB has upped its target price to 92 US cents, while DBS has kept its target price at 85 US cents.
×